Anti-B cell lymphoma A20-HL Idiotype x Anti-CD3 Bispecific Antibody (IgG-IgG) (BSIG-015)

Anti-B cell lymphoma A20-HL Idiotype x Anti-CD3 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-B cell lymphoma A20-HL Idiotype and anti-CD3 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can block cell adhesion. It is designed for the research of B cell lymphoma therapy.

Datasheet INQUIRY

Specifications

Targets

B cell lymphoma A20-HL Idiotype & CD3

Type

IgG-IgG

Species Reactivity

Mouse

Application

FuncS; Promising therapeutic agent

Related Disease

B cell lymphoma

Targets

Target 1

B cell lymphoma A20-HL Idiotype

Alternative Names

B cell lymphoma A20-HL Idiotype; B cell lymphoma; A20-HL ; Idiotype; Id

Target 2

CD3

Gene ID

12501

UniProt ID

P24161

Alternative Names

CD3; CD3E; CD3e molecule; Cluster of differentiation 3; CD3e molecule, epsilon (CD3-TCR complex); T3E; TCRE; IMD18; T-cell surface glycoprotein CD3 epsilon chain; CD3-epsilon; T-cell surface antigen T3/Leu-4 epsilon chain; CD3e antigen, epsilon polypeptide (TiT3 complex); T-cell antigen receptor complex, epsilon subunit of T3; AI504783

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Related products of "B cell lymphoma A20-HL Idiotype & CD3"

See other bsAb targets related to "CD3"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-B cell lymphoma A20-HL Idiotype x Anti-CD3 Bispecific Antibody (IgG-IgG) (BSIG-015). Click the button below to contact us or submit your feedback about this product.

Anti-B cell lymphoma A20-HL Idiotype x Anti-CD3 Bispecific Antibody (IgG-IgG) (CAT#: BSIG-015)

Specifications

Targets

Customer Reviews and Q&As